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Abstract
Background: Surgical resection of colorectal liver metastases (CLM) is an established form of treatment.
Limited data exists on the value of sequential hepatic and pulmonary metastasectomy. We analysed
patients who underwent sequential liver and lung resections for CLM.
Methods: A total of 910 patients who underwent liver resection for CLM between January 2000 and
December 2007, were analysed to identify patients with resectable pulmonary metastases (n = 43; 4.7%).
Patient demographics, overall survival and survival difference between synchronous and metachronous
pulmonary metastasectomy groups were compared. In addition, outcomes in the ‘liver and lung resection’
group were compared with a matched group of ‘liver resection only’ patients (matched for age, primary
disease stage, interval to liver resection and liver disease stage).
Results: Forty-three patients (median age 62, range 43–83 years, 22 males) underwent sequential liver
and lung resection. A total of 36 patients underwent major hepatic resections, 18 patients had bilobar
disease and the median number of liver lesions resected was 3 (range 1–5 lesions). Ten patients had
synchronous liver and lung metastases. The median interval between liver and lung metastasectomy was
25 months (range 2–88 months). A total of two patients underwent major lobectomies, three patients had
bilateral disease and the median number of lung lesions resected was one (range 1–3). The 1-, 3- and
5-year overall survival rates after first metastasectomy were 100%, 87.1% and 53.9%, respectively, with
a median survival of 42 months.
Patients: Undergoing metachronous pulmonary metastasectomy had better 1-, 3- and 5-year survival
rates than those with synchronous disease (100%, 88.9% and 60.9% vs. 100%, 75% and 0%, respec-
tively; P = 0.02, log rank test). There was no significant survival difference between the ‘liver and lung
resection’ and the ‘liver resection only’ groups.
Conclusion: Sequential liver and lung resection for CLM is associated with good long-term survival in
selected patients, except in those presenting with synchronous lung and liver metastases.
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Introduction
The most common sites for haematogenous metastases from col-
orectal carcinoma are the liver and lung.1 Surgical resection of
hepatic and pulmonary colorectal metastases is an established
form of treatment for stage 4 colorectal cancer.2–7 Studies have
reported 5-year survival of up to 58% after isolated hepatic
metastasectomy.5,8–11 Similarly, 5-year survival rates of 36–45%
were reported after resection of lung metastases from colorectal
cancer.7,12–14 However, limited data are available on the value of
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sequential resections of liver and lung colorectal cancer
metastases. A study on the outcomes after resection of synchro-
nous or metachronous hepatic and pulmonary colorectal
metastases, by Miller et al. concluded that surgical resection was
associated with prolonged survival in selected patients.15 Patients
with a longer disease-free interval between metastases and those
with single liver lesions had the best outcomes.
The purpose of this study was to evaluate the long-term
outcome of sequential hepatic and pulmonary metastasectomy
from colorectal cancer and to identify factors that predict survival.
Patients and methods
All patients who underwent liver resection for colorectal cancer
metastases at the University Hospital of Birmingham between
January 2000 and December 2007 were retrospectively analysed to
identify patients who had either synchronous or metachronous
pulmonary metastases. Synchronous pulmonary metastasis was
defined as the development of a lung lesion within 6 months of
liver resection. All patients included in the study had received
adjuvant chemotherapy after resection of primary colorectal
cancer.
The data on liver resections were obtained from the prospec-
tively maintained Liver Unit database at the Queen Elizabeth Hos-
pital, Birmingham. The lung resection data were retrieved from
the Pathology database at the Birmingham Heartlands Hospital.
Selection criteria
The criteria for hepatic metastasectomy were as follows: techni-
cally resectable liver secondaries leaving behind an adequate
hepatic residual volume, and the absence of extra-hepatic
metastasis other than resectable pulmonary metastases. Similarly
the criteria for pulmonary metastasectomy included technically
resectable lung metastases, absence of extra-thoracic metastasis
other that resectable liver metastases and adequate cardiopulmo-
nary function enabling complete resection of all pulmonary
tumours.
Surgical techniques
During liver resection, all patients were explored using a subcostal
incision. A thorough intra-abdominal exploration was carried out
to identify any extra-hepatic disease. Intra-operative ultrasound
was used in all patients to assess the number and extent of liver
tumours and their relation to vascular anatomy. Pulmonary resec-
tion was performed after a minimum of 6–8 weeks after liver
resection, after assessing the patient as being fit for a thoracotomy.
Follow-up
After hepatic or pulmonary metastatic resection, patients were
closely followed up clinically, radiologically and biochemically.
Surveillance computed tomography (CT) scans of the thorax,
abdomen and pelvis were performed at 12 and 24 months after
resection or when clinically indicated or when the tumour
markers were elevated. Serum carcinoembryonic antigen (CEA)
levels were measured every 3 months.
Data analysis
The following parameters were analysed: patient demographics,
Duke’s stage of primary colorectal cancer, number of liver
metastases, interval between primary colorectal surgery and liver
resection and between liver and lung resections. The overall 1-, 3-
and 5-year survival after first metastasectomy and the survival
difference between synchronous and metachronous pulmonary
metastasectomy were also analysed. Survival difference was also
compared between the ‘liver and lung resection’ group and a
matched ‘liver resection only’ group without pulmonary
metastases. Both these groups were matched for age, gender, stage
of primary colorectal cancer, number of liver metastases and
interval between colorectal surgery and liver resection.
Statistics
Data analysis was done with SPSS for Windows® software (version
13; Chicago, IL, USA). The overall survival was evaluated using
Kaplan–Meier analysis and survival curves were compared using
the Log-rank test. Factors possibly predicting survival were evalu-
ated by univariate analysis.
Results
Of the 910 patients who had liver resection (median age, range,
gender) for colorectal metastases during the study period, 43
patients (4.7%) underwent sequential liver and lung resections.
The median age at the time of presentation of liver metastasis was
62 years (range 43–83 years). There were 22 men and 21 women.
The primary colorectal tumour was staged as Duke’s B in 9
patients, Duke’s C in 28 patients and Duke’s D in 6 patients, all of
whom had synchronous liver metastases. None of these six
patients had lung metastasis at the time of detection of colonic
and liver disease. The interval between colonic surgery and liver
resection ranged from 4 to 66 months with a median of 19
months. None of the patients had simultaneous colonic and liver
metastasis resection.
All the patients received adjuvant chemotherapy after colonic
resection. Twenty-six patients received 5-FU/Folinic acid, 13
patients received oxaliplatin-based chemotherapy and 4 patients
had irinotecan-based chemotherapy. Patients with metachronous
liver metastasis went on to have surgical resection of metastasis
first followed by additional chemotherapy. Patients with synchro-
nous lung metastasis had sequential resection of liver and lung
lesions followed by additional chemotherapy, if fit. However,
patients with metachronous lung metastasis had resection
without further chemotherapy, as they would have had chemo-
therapy after liver resection.
Hepatic resection
A total of 44 liver resections were performed on 43 patients. The
type of liver resections performed is shown in Fig. 1. One patient
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who had non-anatomical resection of segment 4 initially devel-
oped recurrence within 5 months. He subsequently underwent a
right hemihepatectomy with non-anatomical resection. Major
liver resection, defined as resection of 3 or more Couinaud’s seg-
ments was performed in 36 patients (81.8%). Eighteen patients
(40.9%) had bilobar disease.
Final histopathological examination of resected liver specimens
confirmed the number of liver lesions to vary from 1 to 5, with the
median being 3. Nine patients had solitary liver metastases, 12
patients had 2 lesions, 17 patients had 3, 4 patients had 4 and 2
patients had 5 lesions each. All tumours were resected with histo-
logical clear margins (median 5 mm, range 3 mm to 5 cm)
Pulmonary resection
The median interval between liver and lung metastasectomy was
25 months (range: 2–88 months). Ten patients had synchronous
liver and lung metastasis and the remaining 33 patients had
metachronous metastasis.
A total of 45 pulmonary resections were performed on 43
patients. Two patients developed recurrence, one within 3 months
and the other in 12 months, necessitating repeat resections. Wedge
resection of pulmonary metastases was performed in all but two
patients, both of whom had lobectomies. Three patients had bilat-
eral disease. The most common site of pulmonary metastasis was
the right lower lobe in 23 patients (51.1%) followed by the left
lower lobe in 12 patients (26.7%). The median number of lung
metastasis resected was 1 (range: 1–3).
Overall survival and prognostic factors
The overall survival was calculated from the time of first metasta-
sectomy. The actuarial overall survival after sequential liver and
lung metastasectomy was 100% at 1 year, 87.1% at 3 years
and 53.9% at 5 years, with a median survival of 42 months
(range:3–96 months) (Fig. 2). Analysis of the risk factors revealed
that the presence of metachronous liver and lung metastases was
significantly associated with better survival than synchronously
detected lesions (P = 0.02) (Fig. 3), although age, gender (Fig. 4),
Duke’s stage of primary colorectal tumour (Fig. 5), number of
liver and lung lesions (Fig. 6) and the interval between primary
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Figure 1 Type of liver resections performed
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Figure 2 Cumulative survival curve, calculated from first metasta-
sectomy for patients who underwent both hepatic and pulmonary
metastatic resections
HPB 673
HPB 2009, 11, 671–676 © 2009 International Hepato-Pancreato-Biliary Association
colorectal cancer resection and liver surgery were not (Table 1).
The 1-, 3- and 5-year overall survival for the metachronous pul-
monary metastasectomy group was 100%, 88.9% and 60.9%,
respectively, with a median survival of 52 months, compared
with 100%, 75% and 0%, respectively, for the synchronous pul-
monary metastasectomy group with a median survival of 12
months.
Patient’s overall survival in the ‘liver and lung resection’ group
was comparable with that of matched ‘liver resection only’ group,
without pulmonary metastasis. The 1-, 3- and 5-year survival of
the ‘liver and lung resection’ group was 100%, 87.1% and 53.9%,
respectively, as compared with 96.9%, 84.5% and 51.5% in the
‘liver resection’ only group.
Discussion
The results of this study have demonstrated that good long-term
survival could be achieved after combined liver and lung resec-
tions for metastases from colorectal cancer in selected group of
patients.
The overall 5-year survival in the present study was 53.9%. This
was comparable to the 5-year survival rates reported by Mineo
et al. and Takahashi et al.16,17 The high 5-year survival rates could
be attributed to the aggressive surgical approach, selection of
patients with biologically less aggressive disease, strict post-
operative follow-up, early identification of metastasis and newer
generation of chemotherapeutic agents. Even although adjuvant
oxaliplatin-based chemotherapy has been proved to improve
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Figure 3 Cumulative survival curves comparing synchronous vs.
metachronous pulmonary metastasectomy groups
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Figure 4 Cumulative survival curves comparing male and female
subgroups
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Figure 5 Cumulative survival curves comparing Dukes' stage of the
primary colonic cancer
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Figure 6 Cumulative survival curves comparing number of liver
lesions resected
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survival, Takahashi et al. obtained similar 5-year survival rates with
surgical treatment only.17 None of their patients received chemo-
therapy. They believed that this selected group of patients might
have unique tumour characteristics that favour better outcome.
Controversy still exists over the prognostic factors which
predict better survival after surgical resection. Our study demon-
strated that overall survival is significantly better if pulmonary
metastasis developed more than 6 months after liver resection
(metachronous group) as compared with those who developed
within 6 months of liver resection (synchronous group) (5-year
survival of 60.9% vs. 0%). Several studies have confirmed similar
results.18–20 Nagakura et al. reported that sequentially detected
hepatic and pulmonary metastases was the strongest favourable
prognostic factor.20 These authors concluded that simultaneous
detection of these metastases does not warrant resection.
A number of other factors have been mentioned to significantly
affect outcome after resection. These include age, number of
metastasis, short disease free interval, high levels of CEA before
metastasectomy, mediastinal nodal involvement and bilateral or
multiple lung metastasis.15,16,18,19,21–24 The type of liver and lung
resection has not been proven to influence outcome. However,
several studies have shown better survival with adequate margin
clearance.3–6 The present study analysed factors such as age,
gender, stage of primary colorectal cancer, number of liver and
lung lesions, interval between primary and liver surgery and none
of them were found to influence outcome. It is possible that as the
number of patients in this study was small, we were underpowered
to identify a true prognostic factor. This could also reflect the
inclusion of the selected group of patients with favourable tumour
characteristics.
Comparing the survival difference between patients who
underwent hepatic and pulmonary metastasectomy with those
who had isolated hepatic metastasectomy (without pulmonary
metastasis), we found a marginally better 5-year survival in the
former group (53.9% vs. 51.5%), although the difference was not
statistically significant. Miller et al. reported that the 5-year sur-
vival after liver and lung resection was 49% as compared with only
37% after hepatectomy for colorectal metastasis.15 Similar findings
were shown by Shah and associates.25 This supports the notion
that multisite metastases from colorectal cancer should not
preclude potential curative resection. The likely reason for this
finding could be the fact that this group of patients is representa-
tive of a subset of patients with favourable tumour biology. Par-
ticularly patients developing second resectable metastasis after
first metastasectomy represent a different subgroup compared
with the cohort of patients undergoing hepatic metastasectomy,
most of whom develop extensive extra-hepatic disease.
The limitations of this study are the small size of the study
group and retrospective nature of data analysis, even although
these patients were identified on a prospective database. This
highly selected patient population is likely to have favourable
tumour characteristics, and is probably different than the popu-
lation of patients with colorectal metastasis alone. Despite the
limitations, the study does suggest a favourable outcome in
patients with a longer interval between hepatic and pulmonary
resection, which needs to be verified in large multicentre cohorts/
studies.
In conclusion, sequential liver and lung resection for metastases
from colorectal cancer is associated with satisfactory long-term
survival in selected patients, with the exception of those present-
ing with synchronous liver and lung metastases.
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